The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate
Watts, N., Amann, M., Arnell, N., Ayeb-Karlsson, S., Belesova, K., Boykoff, M., Byass, P., Cai, W., Campbell-Lendrum, D., Capstick, S., Chambers, J., Dalin, C., Daly, M., Dasandi, N., Davies, M., Drummond, P., Dubrow, R., Ebi, K.L., Eckelman, M., Ekins, P., Escobar, L.E., Fernandez Montoya, L., Georgeson, L., Graham, H., Haggar, P., Hamilton, I., Hartinger, S., Hess, J., Kelman, I., Kiesewetter, G., Kjellstrom, T., Kniveton, D., Lemke, B., Liu, Y., Lott, M., Lowe, R., Sewe, M.O., Martinez-Urtaza, J., Maslin, M., McAllister, L., McGushin, A., Jankin Mikhaylov, S., Milner, J., Moradi-Lakeh, M., Morrissey, K., Murray, K., Munzert, S., Nilsson, M., Neville, T., Oreszczyn, T., Owfi, F., Pearman, O., Pencheon, D., Phung, D., Pye, S., Quinn, R., Rabbaniha, M., Robinson, E., Rocklöv, J., Semenza, J.C., Sherman, J., Shumake-Guillemot, J., Tabatabaei, M., Taylor, J., Trinanes, J., Wilkinson, P., Costello, A., Gong, P., Montgomery, H.
Rapid Risk Assessment: Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia
This rapid risk assessment aims to assess the risk of XDR Neisseria gonorrhoeae spreading further in the EU/EEA and provide some options for response.
ECDC: first detected cases of extensively drug-resistant gonorrhoea threaten future treatment
Within a matter of weeks, three cases of gonorrhoea that are resistant to the recommended first line antibiotic treatment have been detected in Europe and Australia. These are the first global reports of Neisseria gonorrhoeae with high-level resistance to azithromycin and ceftriaxone resistance that also show resistance to several other vital antibiotics. At a time with limited alternatives to the current dual therapy, lack of a vaccine and insufficient surveillance capacity in some regions, these cases highlight the growing threat of drug-resistance – which could lead to untreatable gonorrhoea.
Communicable disease threats report, 23 July - 29 July, week 30
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23 July - 29 July 2017 and includes updates on measles, seasonal influenza, West Nile fever, legionnaires' disease and chikungunya, dengue and Zika viruses.
Oseltamivir-resistant influenza A(H1N1)pdm09 patterns across the globe: findings in Australia (season 2011) and United States (season 2010-11)Archived
In this letter the authors describe being able to identified a sustained community transmission of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Australia
Rapid risk assessment: Oseltamivir-resistant influenza A(H1N1)2009 cluster in Australia
Australia has reported a cluster of oseltamivir-resistant influenza A(H1N1)2009 cases in the state of New South Wales. The cases had no known link to oseltamivir exposure and individuals were not immunosuppressed, but they were closely linked geographically. Samples from the cluster do not currently exhibit any resistance to zanamivir.
The extinction of dengue through natural vulnerability of its vectorsArchived
Aedes aegypti is a highly specialized mosquito species feeding predominantly on humans and breeding in artificial water holding containers in urban areas, and currently restricted to subtropical and tropical areas. Williams et al. focus on the reasons why Ae. aegypti once occurred in locations where the mosquito does not occur anymore in Australia, the more temperate drier parts of the country.